Development of a Rapid Surveillance System for Ross River Virus in Mosquitoes Through Reverse-Transcription Loop-Mediated Isothermal Amplification (RT-LAMP)
{"title":"Development of a Rapid Surveillance System for Ross River Virus in Mosquitoes Through Reverse-Transcription Loop-Mediated Isothermal Amplification (RT-LAMP)","authors":"Alexandra Knox, Gemma Zerna, Travis Beddoe","doi":"10.1155/tbed/1772438","DOIUrl":null,"url":null,"abstract":"<div>\n <p>The global rise in arboviral diseases can be attributed to the ongoing effects of climate change. Ross River virus (RRV) is an illustrative example of such diseases, with case reports in Australia experiencing a significant surge since 2020. RRV is transmitted to susceptible species, such as horses and humans, through multiple mosquito vectors, namely <i>Culex annulirostris</i>, <i>Aedes camptorhynchus</i>, and more recently <i>Ae. notoscriptus</i>. This disease is not only endemic to Australia but has caused outbreaks in surrounding countries such as Fiji and Papua New Guinea. Currently, there are no therapeutic regimes or vaccinations available for RRV, leaving public health warning systems and advice relying upon disease prediction and surveillance. Commonly utilised methods, such as predictive modelling, are experiencing challenges resulting from an increased mosquito presence and extreme weather patterns, often yielding inaccurate advice. Reverse-transcription quantitative polymerase chain reaction (RT-qPCR) provided a promising solution to mitigate these challenges and is now considered the gold standard in many Australian states. However, this method must be performed in a laboratory setting and requires expensive machinery, thus rendering it inadequate for resource-poor or rural communities. Reverse-transcription loop-mediated isothermal amplification (RT-LAMP) serves as a simple and field-deployable substitute with comparable sensitivities and specificity to RT-qPCR, whilst possessing the ability to provide rapid results within 20 min. This paper describes a novel RRV RT-LAMP assay that can detect RRV in as little as one mosquito, with a limit of detection of 1 × 10<sup>−7</sup> ng/µl (~620 copies/µl) and a clinical sensitivity of 84%. Through the addition of tetramethylammonium chloride (TMAC), our assay achieved a 100% specificity and was able to detect RRV RNA as early as 2 min in crude field samples. The simplistic sampling method coupled with our RRV RT-LAMP assay can provide an in-field and low-cost alternative to current routine surveillance techniques.</p>\n </div>","PeriodicalId":234,"journal":{"name":"Transboundary and Emerging Diseases","volume":"2025 1","pages":""},"PeriodicalIF":3.5000,"publicationDate":"2025-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1155/tbed/1772438","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Transboundary and Emerging Diseases","FirstCategoryId":"97","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1155/tbed/1772438","RegionNum":2,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0
Abstract
The global rise in arboviral diseases can be attributed to the ongoing effects of climate change. Ross River virus (RRV) is an illustrative example of such diseases, with case reports in Australia experiencing a significant surge since 2020. RRV is transmitted to susceptible species, such as horses and humans, through multiple mosquito vectors, namely Culex annulirostris, Aedes camptorhynchus, and more recently Ae. notoscriptus. This disease is not only endemic to Australia but has caused outbreaks in surrounding countries such as Fiji and Papua New Guinea. Currently, there are no therapeutic regimes or vaccinations available for RRV, leaving public health warning systems and advice relying upon disease prediction and surveillance. Commonly utilised methods, such as predictive modelling, are experiencing challenges resulting from an increased mosquito presence and extreme weather patterns, often yielding inaccurate advice. Reverse-transcription quantitative polymerase chain reaction (RT-qPCR) provided a promising solution to mitigate these challenges and is now considered the gold standard in many Australian states. However, this method must be performed in a laboratory setting and requires expensive machinery, thus rendering it inadequate for resource-poor or rural communities. Reverse-transcription loop-mediated isothermal amplification (RT-LAMP) serves as a simple and field-deployable substitute with comparable sensitivities and specificity to RT-qPCR, whilst possessing the ability to provide rapid results within 20 min. This paper describes a novel RRV RT-LAMP assay that can detect RRV in as little as one mosquito, with a limit of detection of 1 × 10−7 ng/µl (~620 copies/µl) and a clinical sensitivity of 84%. Through the addition of tetramethylammonium chloride (TMAC), our assay achieved a 100% specificity and was able to detect RRV RNA as early as 2 min in crude field samples. The simplistic sampling method coupled with our RRV RT-LAMP assay can provide an in-field and low-cost alternative to current routine surveillance techniques.
期刊介绍:
Transboundary and Emerging Diseases brings together in one place the latest research on infectious diseases considered to hold the greatest economic threat to animals and humans worldwide. The journal provides a venue for global research on their diagnosis, prevention and management, and for papers on public health, pathogenesis, epidemiology, statistical modeling, diagnostics, biosecurity issues, genomics, vaccine development and rapid communication of new outbreaks. Papers should include timely research approaches using state-of-the-art technologies. The editors encourage papers adopting a science-based approach on socio-economic and environmental factors influencing the management of the bio-security threat posed by these diseases, including risk analysis and disease spread modeling. Preference will be given to communications focusing on novel science-based approaches to controlling transboundary and emerging diseases. The following topics are generally considered out-of-scope, but decisions are made on a case-by-case basis (for example, studies on cryptic wildlife populations, and those on potential species extinctions):
Pathogen discovery: a common pathogen newly recognised in a specific country, or a new pathogen or genetic sequence for which there is little context about — or insights regarding — its emergence or spread.
Prevalence estimation surveys and risk factor studies based on survey (rather than longitudinal) methodology, except when such studies are unique. Surveys of knowledge, attitudes and practices are within scope.
Diagnostic test development if not accompanied by robust sensitivity and specificity estimation from field studies.
Studies focused only on laboratory methods in which relevance to disease emergence and spread is not obvious or can not be inferred (“pure research” type studies).
Narrative literature reviews which do not generate new knowledge. Systematic and scoping reviews, and meta-analyses are within scope.